2023 proved to be a challenging year for many companies operating in the commercial and consumer technology verticals we cover. For many businesses, 2023 was a year of operational normalization,… Read more »
Intrepid Investment Bankers, a leading middle-market investment bank, announced today that it acted as the buyside advisor to iWave, a portfolio company of Incline Equity Partners, on its merger with… Read more »
Intrepid Capital Advisory MARKET MOMENTS THAT MATTER Roses are red, violets are blue, lenders pair up, and that matters to you! Read more in our latest monthly update below and… Read more »
Recap of 2023: Deal Making Hits a Multi-Decade Trough After the M&A frenzy in 2021 and early 2022, transaction volume began to decline in the back half of 2022 and… Read more »
Beauty Care M&A ended the year showing signs of increased momentum, closing Q4’23 with 25 transactions, a 19% increase from a depressed Q3’23 and a 17% decrease from Q4’22. Despite… Read more »
Capital providers are storming into 2024 with guns blazing, given most fell short of their deployment goals last year. That said, closing a capital raise deal this year will be… Read more »
We’re excited to share our exclusive report to kick off the year: 2023 Healthcare Wrap-Up and Themes to Watch in 2024! Here’s a glimpse of what’s inside: Reflecting on 2023:… Read more »
Intrepid Investment Bankers announced today that it acted as the buy-side advisor to Vivify Specialty Ingredients (“Vivify”), a portfolio company of Gryphon Investors (“Gryphon”), on its acquisition of Access Ingredients… Read more »
Intrepid Investment Bankers (“Intrepid”), a leading middle-market investment bank, announced today that it acted as the buy-side advisor to Russell Reynolds Associates (“RRA”), on its acquisition of Savage Partners. RRA… Read more »